Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 506 entries
Sorted by: Best Match Show Resources per page
Culturally responsive social emotional learning for international students: Professional development for higher education

Asset based approaches STEM training

Jaiswal-Oliver M, Sharma R, Yeh E.
GSID: c0R8dGpSg7kJ
E Yeh, R Sharma, M Jaiswal-Oliver, G Wan - Journal of International Students, 2022 - ERIC

… cultural and linguistic diversity as assets, applying culturally mediated instruction, and … -based approach for English language learning students who are in STEM education. While …

Cite
Yeh, E., Sharma, R., Jaiswal-Oliver, M., & Wan, G. (2022). Culturally responsive social emotional learning for international students: Professional development for higher education. Journal of International Students, 12(1), 19-41.
Yeh, Ellen, et al. "Culturally responsive social emotional learning for international students: Professional development for higher education." Journal of International Students 12.1 (2022): 19-41.
Copy Download .nbib Format: MLA
Association of a congenital long QT syndrome type 1 with Takotsubo cardiomyopathy.

Clinical case reports

El-Battrawy I, Behnes M, Borggrefe M, Akin I.
PMID: 27525086
Clin Case Rep. 2016 Jul 12;4(8):789-92. doi: 10.1002/ccr3.567. eCollection 2016 Aug.

The occurrence of takotsubo cardiomyopathy in a patient with congenital long QT syndrome has rarely been described. This case report discusses the occurrence of a clinically overt takotsubo cardiomyopathy accompanied by congenital long QT syndrome type 1 in a...

Cite
El-Battrawy I, Behnes M, Borggrefe M, et al. Association of a congenital long QT syndrome type 1 with Takotsubo cardiomyopathy. Clin Case Rep. 2016;4(8):789-92doi: 10.1002/ccr3.567.
El-Battrawy, I., Behnes, M., Borggrefe, M., & Akin, I. (2016). Association of a congenital long QT syndrome type 1 with Takotsubo cardiomyopathy. Clinical case reports, 4(8), 789-92. https://doi.org/10.1002/ccr3.567
El-Battrawy, Ibrahim, et al. "Association of a congenital long QT syndrome type 1 with Takotsubo cardiomyopathy." Clinical case reports vol. 4,8 (2016): 789-92. doi: https://doi.org/10.1002/ccr3.567
El-Battrawy I, Behnes M, Borggrefe M, Akin I. Association of a congenital long QT syndrome type 1 with Takotsubo cardiomyopathy. Clin Case Rep. 2016 Jul 12;4(8):789-92. doi: 10.1002/ccr3.567. eCollection 2016 Aug. PMID: 27525086; PMCID: PMC4974430.
Copy Download .nbib Format: NLM
Corrigendum: Lanosterol reverses protein aggregation in cataracts.

Nature

Zhao L, Chen XJ, Zhu J, Xi YB, Yang X, Hu LD, Ouyang H, Patel SH, Jin X, Lin D, Wu F, Flagg K, Cai H, Li G, Cao G, Lin Y, Chen D, Wen C, Chung C, Wang Y, Qiu A, Yeh E, Wang W, Hu X, Grob S, Abagyan R, Su Z, Tjondro HC, Zhao XJ, Luo H, Hou R, Perry JJ, Gao W, Kozak I, Granet D, Li Y, Sun X, Wang J, Zhang L, Liu Y, Yan YB, Zhang K.
PMID: 26308894
Nature. 2015 Oct 22;526(7574):595. doi: 10.1038/nature15253. Epub 2015 Aug 26.

No abstract available.

Cite
Zhao L, Chen XJ, Zhu J, et al. Corrigendum: Lanosterol reverses protein aggregation in cataracts. Nature. 2015;526(7574):595doi: 10.1038/nature15253.
Zhao, L., Chen, X. J., Zhu, J., Xi, Y. B., Yang, X., Hu, L. D., Ouyang, H., Patel, S. H., Jin, X., Lin, D., Wu, F., Flagg, K., Cai, H., Li, G., Cao, G., Lin, Y., Chen, D., Wen, C., Chung, C., Wang, Y., Qiu, A., Yeh, E., Wang, W., Hu, X., Grob, S., Abagyan, R., Su, Z., Tjondro, H. C., Zhao, X. J., Luo, H., Hou, R., Perry, J. J., Gao, W., Kozak, I., Granet, D., Li, Y., Sun, X., Wang, J., Zhang, L., Liu, Y., Yan, Y. B., & Zhang, K. (2015). Corrigendum: Lanosterol reverses protein aggregation in cataracts. Nature, 526(7574), 595. https://doi.org/10.1038/nature15253
Zhao, Ling, et al. "Corrigendum: Lanosterol reverses protein aggregation in cataracts." Nature vol. 526,7574 (2015): 595. doi: https://doi.org/10.1038/nature15253
Zhao L, Chen XJ, Zhu J, Xi YB, Yang X, Hu LD, Ouyang H, Patel SH, Jin X, Lin D, Wu F, Flagg K, Cai H, Li G, Cao G, Lin Y, Chen D, Wen C, Chung C, Wang Y, Qiu A, Yeh E, Wang W, Hu X, Grob S, Abagyan R, Su Z, Tjondro HC, Zhao XJ, Luo H, Hou R, Perry JJ, Gao W, Kozak I, Granet D, Li Y, Sun X, Wang J, Zhang L, Liu Y, Yan YB, Zhang K. Corrigendum: Lanosterol reverses protein aggregation in cataracts. Nature. 2015 Oct 22;526(7574):595. doi: 10.1038/nature15253. Epub 2015 Aug 26. PMID: 26308894.
Copy Download .nbib Format: NLM
Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan.

Journal of Cancer

Chou WC, Chang PH, Lu CH, Liu KH, Hung YS, Hung CY, Liu CT, Yeh KY, Lin YC, Yeh TS.
PMID: 27162545
J Cancer. 2016 Apr 28;7(7):854-61. doi: 10.7150/jca.14777. eCollection 2016.

PURPOSE: Patients with comorbidities are more likely to experience treatment-related toxicities and death. Our aim was to examine the effect of comorbidity on postoperative survival outcomes in patients with solid cancers.METHODS: In total, 37,288 patients who underwent potentially curative...

Cite
Chou WC, Chang PH, Lu CH, et al. Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan. J Cancer. 2016;7(7):854-61doi: 10.7150/jca.14777.
Chou, W. C., Chang, P. H., Lu, C. H., Liu, K. H., Hung, Y. S., Hung, C. Y., Liu, C. T., Yeh, K. Y., Lin, Y. C., & Yeh, T. S. (2016). Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan. Journal of Cancer, 7(7), 854-61. https://doi.org/10.7150/jca.14777
Chou, Wen-Chi, et al. "Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan." Journal of Cancer vol. 7,7 (2016): 854-61. doi: https://doi.org/10.7150/jca.14777
Chou WC, Chang PH, Lu CH, Liu KH, Hung YS, Hung CY, Liu CT, Yeh KY, Lin YC, Yeh TS. Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan. J Cancer. 2016 Apr 28;7(7):854-61. doi: 10.7150/jca.14777. eCollection 2016. PMID: 27162545; PMCID: PMC4860803.
Copy Download .nbib Format: NLM
Correction: Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population.

Oncotarget

Li L, Dang Q, Xie H, Yang Z, He D, Liang L, Song W, Yeh S, Chang C.
PMID: 28082728
Oncotarget. 2016 Dec 13;7(50):83828. doi: 10.18632/oncotarget.13912.

No abstract available.

Cite
Li L, Dang Q, Xie H, et al. Correction: Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Oncotarget. 2016;7(50):83828doi: 10.18632/oncotarget.13912.
Li, L., Dang, Q., Xie, H., Yang, Z., He, D., Liang, L., Song, W., Yeh, S., & Chang, C. (2016). Correction: Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Oncotarget, 7(50), 83828. https://doi.org/10.18632/oncotarget.13912
Li, Lei, et al. "Correction: Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population." Oncotarget vol. 7,50 (2016): 83828. doi: https://doi.org/10.18632/oncotarget.13912
Li L, Dang Q, Xie H, Yang Z, He D, Liang L, Song W, Yeh S, Chang C. Correction: Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Oncotarget. 2016 Dec 13;7(50):83828. doi: 10.18632/oncotarget.13912. PMID: 28082728; PMCID: PMC5341255.
Copy Download .nbib Format: NLM
Same song, different audience: pharmaceutical promotion targeting non-physician health care providers.

PLoS medicine

Yeh JS, Kesselheim AS.
PMID: 24302891
PLoS Med. 2013 Nov;10(11):e1001560. doi: 10.1371/journal.pmed.1001560. Epub 2013 Nov 26.

No abstract available.

Cite
Yeh JS, Kesselheim AS. Same song, different audience: pharmaceutical promotion targeting non-physician health care providers. PLoS Med. 2013;10(11):e1001560doi: 10.1371/journal.pmed.1001560.
Yeh, J. S., & Kesselheim, A. S. (2013). Same song, different audience: pharmaceutical promotion targeting non-physician health care providers. PLoS medicine, 10(11), e1001560. https://doi.org/10.1371/journal.pmed.1001560
Yeh, James S, and Kesselheim, Aaron S. "Same song, different audience: pharmaceutical promotion targeting non-physician health care providers." PLoS medicine vol. 10,11 (2013): e1001560. doi: https://doi.org/10.1371/journal.pmed.1001560
Yeh JS, Kesselheim AS. Same song, different audience: pharmaceutical promotion targeting non-physician health care providers. PLoS Med. 2013 Nov;10(11):e1001560. doi: 10.1371/journal.pmed.1001560. Epub 2013 Nov 26. PMID: 24302891; PMCID: PMC3841098.
Copy Download .nbib Format: NLM
China's ecosystems: Sacrificing the poor.

Science (New York, N.Y.)

Zinda JA, Hopping KA, Schmitt E, Yeh ET, Harrell S, Anderson EN.
PMID: 27516591
Science. 2016 Aug 12;353(6300):657-8. doi: 10.1126/science.aah4960.

No abstract available.

Cite
Zinda JA, Hopping KA, Schmitt E, et al. China's ecosystems: Sacrificing the poor. Science. 2016;353(6300):657-8doi: 10.1126/science.aah4960.
Zinda, J. A., Hopping, K. A., Schmitt, E., Yeh, E. T., Harrell, S., & Anderson, E. N. (2016). China's ecosystems: Sacrificing the poor. Science (New York, N.Y.), 353(6300), 657-8. https://doi.org/10.1126/science.aah4960
Zinda, John A, et al. "China's ecosystems: Sacrificing the poor." Science (New York, N.Y.) vol. 353,6300 (2016): 657-8. doi: https://doi.org/10.1126/science.aah4960
Zinda JA, Hopping KA, Schmitt E, Yeh ET, Harrell S, Anderson EN. China's ecosystems: Sacrificing the poor. Science. 2016 Aug 12;353(6300):657-8. doi: 10.1126/science.aah4960. PMID: 27516591.
Copy Download .nbib Format: NLM
Frequency of Vascular Inflammation and Impact on Neointimal Proliferation of Drug Eluting Stents in Porcine Coronary Arteries.

Acta Cardiologica Sinica

Yeh JS, Oh SJ, Hsueh CM.
PMID: 27713606
Acta Cardiol Sin. 2016 Sep;32(5):570-577. doi: 10.6515/acs20151013g.

BACKGROUND: We aimed to describe the frequency of vascular inflammatory reactions with second generation drug eluting stents (DES) compared to first generation DES, and analyze the impact on inflammation and neointimal proliferation in a porcine coronary model.METHODS: A total...

Cite
Yeh JS, Oh SJ, Hsueh CM. Frequency of Vascular Inflammation and Impact on Neointimal Proliferation of Drug Eluting Stents in Porcine Coronary Arteries. Acta Cardiol Sin. 2016;32(5):570-577doi: 10.6515/acs20151013g.
Yeh, J. S., Oh, S. J., & Hsueh, C. M. (2016). Frequency of Vascular Inflammation and Impact on Neointimal Proliferation of Drug Eluting Stents in Porcine Coronary Arteries. Acta Cardiologica Sinica, 32(5), 570-577. https://doi.org/10.6515/acs20151013g
Yeh, Jong Shiuan, et al. "Frequency of Vascular Inflammation and Impact on Neointimal Proliferation of Drug Eluting Stents in Porcine Coronary Arteries." Acta Cardiologica Sinica vol. 32,5 (2016): 570-577. doi: https://doi.org/10.6515/acs20151013g
Yeh JS, Oh SJ, Hsueh CM. Frequency of Vascular Inflammation and Impact on Neointimal Proliferation of Drug Eluting Stents in Porcine Coronary Arteries. Acta Cardiol Sin. 2016 Sep;32(5):570-577. doi: 10.6515/acs20151013g. PMID: 27713606; PMCID: PMC5052476.
Copy Download .nbib Format: NLM
Key Features of Academic Detailing: Development of an Expert Consensus Using the Delphi Method.

American health & drug benefits

Yeh JS, Van Hoof TJ, Fischer MA.
PMID: 27066195
Am Health Drug Benefits. 2016 Feb;9(1):42-50.

BACKGROUND: Academic detailing is an outreach education technique that combines the direct social marketing traditionally used by pharmaceutical representatives with unbiased content summarizing the best evidence for a given clinical issue. Academic detailing is conducted with clinicians to encourage...

Cite
Yeh JS, Van Hoof TJ, Fischer MA. Key Features of Academic Detailing: Development of an Expert Consensus Using the Delphi Method. Am Health Drug Benefits. 2016;9(1):42-50
Yeh, J. S., Van Hoof, T. J., & Fischer, M. A. (2016). Key Features of Academic Detailing: Development of an Expert Consensus Using the Delphi Method. American health & drug benefits, 9(1), 42-50.
Yeh, James S, et al. "Key Features of Academic Detailing: Development of an Expert Consensus Using the Delphi Method." American health & drug benefits vol. 9,1 (2016): 42-50.
Yeh JS, Van Hoof TJ, Fischer MA. Key Features of Academic Detailing: Development of an Expert Consensus Using the Delphi Method. Am Health Drug Benefits. 2016 Feb;9(1):42-50. PMID: 27066195; PMCID: PMC4822978.
Copy Download .nbib Format: NLM
FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping.

OncoTargets and therapy

Lu CY, Yeh YS, Huang CW, Ma CJ, Yu FJ, Wang JY.
PMID: 25473295
Onco Targets Ther. 2014 Nov 21;7:2143-6. doi: 10.2147/OTT.S69774. eCollection 2014.

Here we report a case of metastatic colon cancer treated with 5-fluorouracil, leucovorin, and escalated doses of irinotecan (FOLFIRI) combined with regorafenib in the fourth-line setting after uridine diphosphate glucuronosyltransferase (UGT)1A1 genotyping analysis. A 66-year-old male was initially diagnosed...

Cite
Lu CY, Yeh YS, Huang CW, et al. FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping. Onco Targets Ther. 2014;7:2143-6doi: 10.2147/OTT.S69774.
Lu, C. Y., Yeh, Y. S., Huang, C. W., Ma, C. J., Yu, F. J., & Wang, J. Y. (2014). FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping. OncoTargets and therapy, 72143-6. https://doi.org/10.2147/OTT.S69774
Lu, Chien-Yu, et al. "FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping." OncoTargets and therapy vol. 7 (2014): 2143-6. doi: https://doi.org/10.2147/OTT.S69774
Lu CY, Yeh YS, Huang CW, Ma CJ, Yu FJ, Wang JY. FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping. Onco Targets Ther. 2014 Nov 21;7:2143-6. doi: 10.2147/OTT.S69774. eCollection 2014. PMID: 25473295; PMCID: PMC4246994.
Copy Download .nbib Format: NLM
Syntheses of Platinum-Sulindac Complexes and Their Nanoparticles as Targeted Anticancer Drugs.

Chemistry (Weinheim an der Bergstrasse, Germany)

Hwu JR, Tsay SC, Chuang KS, Kapoor M, Lin JY, Yeh CS, Su WC, Wu PC, Tsai TL, Wang PW, Shieh DB.
PMID: 26752423
Chemistry. 2016 Feb;22(6):1926-1930. doi: 10.1002/chem.201504915. Epub 2016 Jan 11.

Platinum(II)-sulindac complexes [{η

Cite
Hwu JR, Tsay SC, Chuang KS, et al. Syntheses of Platinum-Sulindac Complexes and Their Nanoparticles as Targeted Anticancer Drugs. Chemistry. 2016;22(6):1926-1930doi: 10.1002/chem.201504915.
Hwu, J. R., Tsay, S. C., Chuang, K. S., Kapoor, M., Lin, J. Y., Yeh, C. S., Su, W. C., Wu, P. C., Tsai, T. L., Wang, P. W., & Shieh, D. B. (2016). Syntheses of Platinum-Sulindac Complexes and Their Nanoparticles as Targeted Anticancer Drugs. Chemistry (Weinheim an der Bergstrasse, Germany), 22(6), 1926-1930. https://doi.org/10.1002/chem.201504915
Hwu, Jih Ru, et al. "Syntheses of Platinum-Sulindac Complexes and Their Nanoparticles as Targeted Anticancer Drugs." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 22,6 (2016): 1926-1930. doi: https://doi.org/10.1002/chem.201504915
Hwu JR, Tsay SC, Chuang KS, Kapoor M, Lin JY, Yeh CS, Su WC, Wu PC, Tsai TL, Wang PW, Shieh DB. Syntheses of Platinum-Sulindac Complexes and Their Nanoparticles as Targeted Anticancer Drugs. Chemistry. 2016 Feb;22(6):1926-1930. doi: 10.1002/chem.201504915. Epub 2016 Jan 11. PMID: 26752423.
Copy Download .nbib Format: NLM
Resonance analysis of a 2D alluvial valley subjected to seismic waves.

The Journal of the Acoustical Society of America

Chai JF, Teng TJ, Yeh CS, Shyu WS.
PMID: 12186023
J Acoust Soc Am. 2002 Aug;112(2):430-40. doi: 10.1121/1.1494809.

The T-matrix formalism and an ultrasonic experiment are developed to study the scattering of in-plane waves for an alluvial valley embedded in a two-dimensional half-space. The solution of the in-plane scattering problem can be determined by the T-matrix method,...

Cite
Chai JF, Teng TJ, Yeh CS, et al. Resonance analysis of a 2D alluvial valley subjected to seismic waves. J Acoust Soc Am. 2002;112(2):430-40doi: 10.1121/1.1494809.
Chai, J. F., Teng, T. J., Yeh, C. S., & Shyu, W. S. (2002). Resonance analysis of a 2D alluvial valley subjected to seismic waves. The Journal of the Acoustical Society of America, 112(2), 430-40. https://doi.org/10.1121/1.1494809
Chai, Juin-Fu, et al. "Resonance analysis of a 2D alluvial valley subjected to seismic waves." The Journal of the Acoustical Society of America vol. 112,2 (2002): 430-40. doi: https://doi.org/10.1121/1.1494809
Chai JF, Teng TJ, Yeh CS, Shyu WS. Resonance analysis of a 2D alluvial valley subjected to seismic waves. J Acoust Soc Am. 2002 Aug;112(2):430-40. doi: 10.1121/1.1494809. PMID: 12186023.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 506 entries